Memory Pharmaceuticals Corp. (MEMY) is “One to Watch”
Memory Pharmaceuticals (MEMY.PK) is a biopharmaceutical company focused on developing drugs for the treatment of debilitating central nervous system disorders. This New Jersey-based company was founded in 1998 by Nobel Laureate prize winner Dr. Eric Kandel. Memory Pharmaceuticals is working on disorders which exhibit significant impairment of memory and other cognitive functions, including neurological diseases associated with aging such as Alzheimer's disease, and also certain psychiatric disorders such as schizophrenia, bipolar disorder, and depression. The company's products for the treatment of Alzheimer's disease comprise MEM1414, a Phase 1 clinical stage product; Mem1917, a preclinical completed product; and MEM63908, a preclinical…